Drug · DIN 02424770
ACTEMRA
SINGLE-USE PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 30, 2014; first marketed May 30, 2014.
- Drug Identification Number (DIN)
- 02424770
- Company (DIN owner)
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Tocilizumab L04AC07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TOCILIZUMAB | 162 MG | 0.9 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 6, 2014: NOC 15595Supplement to a New Drug Submission (SNDS) · New formulation for subcutaneous administration; new drug product presentation; new manufacturing facility
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “actemra”. A notice may cover another product or only some lots: read it to see what it covers.
- Important Safety Information on ACTEMRA® (tocilizumab) - Risk of HepatotoxicityMay 21, 2019 · Drugs - Biologic or vaccine
Other DINs named ACTEMRA
- DIN 02350092 · Marketed
- DIN 02350106 · Marketed
- DIN 02350114 · Marketed
- DIN 02483327 · Marketed